The Leukemia & Lymphoma Society has awarded three IMPACT (Influential Medicine Providing Access to Clinical Trials) research grants worth a combined total of $3.6 million to Mayo Clinic, Vanderbilt University Medical Center, and Weill Cornell Medicine.
While doing somewhat-routine reporting on this year’s Senate Appropriations Committee bills, Paul Goldberg, editor and publisher of The Cancer Letter, quickly realized that he was seeing a full bipartisan rejection of President Donald J. Trump’s plan to defund and therefore dismantle biomedical research in the United States.
